A GODS™ research page presenting the historical open letter, the Vitamin D3 educational video, and published evidence linking vitamin D status with cathelicidin endpoints.
The letter and video are presented as source materials and historical commentary. They are not presented as current clinical guidance.
Compute the Truth™ Yourself →“Immune and Economic Health for America” · March 23, 2020
Dr.SHIVA™: Vitamin D3 on Immune Health @CytoSolve® Systems Analysis (5/20)
Human cohort data show positive associations between serum vitamin D status and two cathelicidin endpoints. Mechanistic laboratory studies identify active Vitamin D3 as a direct inducer of CAMP transcription.
Cathelicidin antimicrobial peptide is encoded by the CAMP gene. The hCAP18 precursor is processed into LL-37, an antimicrobial peptide involved in innate immune defense. Laboratory studies show that active 1,25-dihydroxyvitamin D3 binds the vitamin D receptor and directly increases CAMP transcription.
The graph reports correlations from the supplied 2026 study, not a dose-response experiment. A higher correlation coefficient indicates a stronger positive association; it does not show how much LL-37 or CAMP would change at a particular Vitamin D3 dose.
The follow-up analysis included 11 supplemented participants with diabetic foot infection and was not a COVID-19 study. Correlation does not establish causation. The paper also reported no statistically significant difference in CAMP gene expression among study, reference, and healthy-control groups at follow-up, despite the significant within-group association.
The letter and video contain historical opinions and educational claims. The page should identify them as source materials and research context. It should not present the historical protocol as individualized medical advice. Current health recommendations require review by a qualified healthcare professional and current evidence.
Review the source materials and published evidence. No GODS™ model result is presented on this page.
